SIMCHA THERAPEUTICS
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. The company uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system. Simcha’s lead program, ST-067, is a designer IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors, as described in Nature in June 2020. It was founded in 2018 and is headquartered in New Haven, Connecticut, USA.
SIMCHA THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.simchatx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alladapt Immunotherapeutics
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Ankyra
Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer.
Artiva Biotherapeutics
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Calithera Biosciences
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
CinCor Pharma
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Cybrexa Therapeutics
Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Eirion Therapeutics
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
GentiBio
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
Immunic Therapeutics
Immunic is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies.
Intergalactic Therapeutics
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
NMB Therapeutics
NMB Therapeutics is a pharmaceutical company that develops products to provide efficient drug delivery.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.
Teon Therapeutics
Teon Therapeutics is a a biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways.
Third Harmonic Bio
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
Umoja Biopharma
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series B - Simcha Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series B - Simcha Therapeutics
BVF Partners
BVF Partners investment in Series B - Simcha Therapeutics
Logos Capital
Logos Capital investment in Series B - Simcha Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - Simcha Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series B - Simcha Therapeutics
Sequoia Capital China
Sequoia Capital China investment in Series A - Simcha Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series A - Simcha Therapeutics
Wuxi Venture Capital Group
Wuxi Venture Capital Group investment in Series A - Simcha Therapeutics
Official Site Inspections
http://www.simchatx.com Semrush global rank: 4.88 M Semrush visits lastest month: 1.8 K
- Host name: 93.26.196.104.bc.googleusercontent.com
- IP address: 104.196.26.93
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
